CFR - Volume 5 Issue 3 Winter 2019

Professors Andrew Coats and Giuseppe Rosano, Dr Cristiana Vitale and the Editorial Board present Volume 5 Issue 3 of Cardiac Failure Review.

In this issue, we focus on clinical practice research and observations an advanced heart failure (HF), a topic of increasing interest to triallists, innovators and practising physicians alike. Highlights include sodium–glucose cotransporter-2 inhibitors and HF prevention in type 2 diabetes, hyperkalemia and renin–angiotensin–aldosterone system inhibitors dose therapy in HF with reduced ejection fraction, inotropes in acute HF and state-of-the-art structural interventions in HF.

The Editorial Team and Publisher hope you find this issue of CFR valuable.